Trial intelligence / Profile preview

Randomized Trial of Aspirin and Cataracts in U.S. Physicians

NCT00000157Phase 3Terminated

Sponsor
National Eye Institute
Start
Apr 1982
Modality
Orthosteric Ligands
01

Overview

Phase 3, randomised, double-blind trial of aspirin in cataract (4 arms), sponsored by National Eye Institute. Primary endpoints: Incidence of cataract at 5 years and Time to cataract diagnosis at 5 years. Started Apr 1982; status: terminated.

02

Drugs

aspirin
03

Conditions

cataract

Beyond the preview

Go deeper on NCT00000157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call